Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 21, 2025 04:59 ET | Source: Research and Markets

Anti-Money Laundering & Know Your Customer - 1 Day Online Training Course, October 10, 2025 | Enhance Your Firm's Resilience Against Financial Crime with FCA Guidance

Dublin, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The "AML and KYC - Anti-Money Laundering & Know Your Customer Training (ONLINE EVENT: October 10, 2025)" has been added to ResearchAndMarkets.com's...
August 14, 2025 09:15 ET | Source: Moleculin Biotech, Inc.

Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

– Live video webcast on Wednesday, August 20th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage...
August 13, 2025 16:30 ET | Source: Aptose Biosciences, Inc.

Aptose Reports Second Quarter 2025 Results

Aptose Reports Second Quarter 2025 Results
July 31, 2025 15:14 ET | Source: Facephi

Ante el crecimiento de ataques de inyección, la tecnológica Facephi toma medidas y planta cara para blindar los procesos digitales.

BUENOS AIRES, Argentina, July 31, 2025 (GLOBE NEWSWIRE) -- Durante los últimos meses, el país fue testigo de cómo enormes volúmenes de datos personales —incluyendo información sensible vinculada a...
July 31, 2025 15:14 ET | Source: Facephi

In response to the rise in injection attacks, technology company Facephi takes action to strengthen and secure digital identity processes

BUENOS AIRES, Argentina, July 31, 2025 (GLOBE NEWSWIRE) -- In recent months, the country has witnessed how vast amounts of personal data — including sensitive information linked to official...
July 30, 2025 01:46 ET | Source: AB Science

AB Science a reçu l’approbation règlementaire de pays européens pour initier la troisième étape de la phase I/II visant à combiner sa molécule AB8939 avec le venetoclax dans le traitement de la LMA

COMMUNIQUÉ DE PRESSE AB SCIENCE A RECU L’APPROBATION REGLEMENTAIRE DE PAYS EUROPEENS POUR INITIER LA TROISIEME ETAPE DE LA PHASE I/II VISANT A COMBINER SA MOLÉCULE AB8939 AVEC LE VENETOCLAX DANS LE...
July 30, 2025 01:46 ET | Source: AB Science

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML

PRESS RELEASE AB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE AB8939 WITH VENETOCLAX FOR THE TREATMENT OF ACUTE...
July 29, 2025 05:48 ET | Source: Lucinity

Lucinity Launches AI-Native Customer 360, Powered by Agentic AI

Lucinity releases a next-generation Customer 360 platform powered by its Agentic AI, Luci, live at a Tier-1 bank.
July 21, 2025 07:18 ET | Source: ImCheck Therapeutics SAS

ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia

ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy...
July 18, 2025 05:00 ET | Source: ImCheck Therapeutics SAS

ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia

ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing...